Top Markets
Coin of the day
Scopus BioPharma Inc. Scopus BioPharma Inc.

Scopus BioPharma Inc.

SCPS
Classificação em ações #41540
Scopus BioPharma Inc. is a biopharmaceutical company in the clinical... Scopus BioPharma Inc. is a biopharmaceutical company in the clinical development phase, dedicated to pioneering innovative treatments for serious diseases. Its core development programs are concentrated on immuno-oncology gene therapies designed to combat various forms of cancer. The company's offerings include the Duet Platform, which incorporates CpG signal transducer and activator of transcription 3 (STAT3) inhibitors. Another significant product is MRI-1867, a cleverly engineered, orally administered, dual-action hybrid small molecule. MRI-1867 functions as an inverse agonist of the endocannabinoid system's cannabinoid receptor 1 (CB1) and additionally acts as an inhibitor of inducible nitric oxide synthase (iNOS). To advance its key development efforts and other programs, Scopus BioPharma has established strategic collaborations with prominent organizations such as the City of Hope, the National Institutes of Health Program, and The Hebrew University of Jerusalem. Established in 2017, the company was originally named Project18 Inc. before officially rebranding to Scopus BioPharma Inc. in December of that year. Its corporate headquarters are located in New York, New York.
Preço da ação
$0.0004
Última sincronização: 2026-08-11
Valor de mercado
$16.83K
Variação (1 dia)
0.00%
Variação (1 ano)
33.33%
País
US
Negociar Scopus BioPharma Inc. (SCPS)

Categoria

Histórico de preços das ações de Scopus BioPharma Inc. (SCPS)
Preço de fecho mais alto: $0.00 em 2026-08-01

Preço de fecho mais baixo: $17.71 em 2020-12-01
Histórico de preços das ações da Scopus BioPharma Inc. de 2020 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) 0.00%
2025 51.79%
2024 -99.40%
2023 -72.25%
2022 -91.18%
2021 -88.82%
2020 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$263.09 18.09%
BE
$1.07K -7.40%
KR